We use cookies to give you the best online experience. By using our website you agree to our use of cookies in accordance with our cookie policy.

list of NY corporations

Alzheimer’s Drug Poses a Dilemma for the F.D.A.


If the agency approves it, aducanumab would be the first new Alzheimer’s treatment since 2003. Patients are desperate for new options, but some scientists say there isn’t enough evidence it works.
read more

Source: NY Times


23:57, June 5, 2021 Pam Belluck and Rebecca Robbins

You may also like

News